Darbepoetin for the treatment of anemia of myelodysplastic syndromes: efficacy and quality of life

被引：0
|
作者：
Oliva, E. N.
Latagliata, R.
Danova, M.
Specchia, G.
Impera, S.
Rovati, B.
Vincelli, I.
Liso, V.
Alimena, G.
Ronco, F.
Carmosino, I.
Risitano, A.
Breccia, M.
Nobile, F.
机构：
[1] Hematol Unit, Az Osp BMM Reggio Calabria, Calabria, Italy
[2] Univ Roma La Sapienza, Dept Hematol, Rome, Italy
[3] Univ S Matteo, Cytometry & Cellular Therapies Unit, Pavia, Italy
[4] Studi Bari Univ, Cattedra Serv Ematol, Bari, Italy
[5] Az Osp, Oncohematol Unit, Catania, Italy
[6] Univ Naples Federico II, Inst Hematol, Naples, Italy
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70212-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S117 / S118
页数：2
相关论文
共 50 条
  • [1] Darbepoetin for the treatment of anemia of myelodysplastic syndromes: Efficacy and improvements in quality of life.
    Oliva, Esther N.
    Latagliata, Roberto
    Danova, Marco
    Vincelli, Iolanda
    Rovati, Bianca
    Ronco, Francesca
    Carmosino, Ida
    Specchia, Giorgina
    Breccia, Massimo
    Impera, Stefana
    Attolico, Imma
    Nobile, Francesco
    BLOOD, 2006, 108 (11) : 754A - 754A
  • [2] Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of life
    Oliva, Esther N.
    Nobile, Francesco
    Alimena, Giuliana
    Specchia, Giorgina
    Danova, Marco
    Rovati, Bianca
    Ronco, Francesca
    Impera, Stefana
    Risitano, Antonio
    Alati, Caterina
    Breccia, Massimo
    Carmosino, Ida
    Vincelli, Iolanda
    Latagliata, Roberto
    LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 1007 - 1014
  • [3] Darbepoetin α for the treatment of anemia in patients with myelodysplastic syndromes
    Giraldo, Pilar
    Nomdedeu, Benet
    Loscertales, Javier
    Requena, Carmen
    de Paz, Raquel
    Tormo, Mar
    Navarro, Pilar
    Benedit, Patricia
    Gasquet, Jose Antonio
    CANCER, 2006, 107 (12) : 2807 - 2816
  • [4] Darbepoetin alfa in anemia of myelodysplastic syndromes: present and beyond
    Kelaidi, C.
    Fenaux, P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (04) : 605 - 614
  • [5] Treatment of anemia in myelodysplastic syndromes
    Fenaux, Pierre
    Kelaidi, Chairikleia
    HEMATOLOGIE, 2006, 12 : 15 - 21
  • [6] Darbepoetin alfa for the treatment of anemia in patients with myelodysplastic syndrome.
    Giraldo, P
    Nomdedeu, B
    Loscertales, J
    Requena, C
    de Paz, R
    Tormo, M
    Navarro, P
    Benedit, P
    Gasquet, JA
    BLOOD, 2005, 106 (11) : 714A - 714A
  • [7] Darbepoetin improves anemia and quality of life in refractory anemia.
    Oliva, EN
    Vincelli, I
    Danova, M
    Morabito, F
    Rovati, B
    Dimitrov, BD
    Panuccio, V
    Nobile, F
    BLOOD, 2003, 102 (11) : 332B - 332B
  • [8] Darbepoetin alfa for anemia with myelodysplastic syndrome
    Seastone, David J.
    Gerds, Aaron T.
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (02) : 139 - 146
  • [9] Quality of life in patients with myelodysplastic syndromes
    Schuler, U.
    CANCER TREATMENT REVIEWS, 2007, 33 : S59 - S63
  • [10] Myelodysplastic syndromes and patient quality of life
    Heptinstall, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 237 - 237
12345